Magnetic resonance imaging targeted biopsy in biopsy‐naïve patients and the risk of overtreatment in prostate cancer: a grading issue
BJU International · 2024
DOI: 10.1111/bju.16221 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJU International, 2024. Verfasst von Teddy Jabbour und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Jules Bordet Institute-Erasme Hospital, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium. Hauptthemen laut MEDLINE: Prostatic Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Objective
To evaluate the impact of applying the 2014 and 2019 International Society of Urological Pathology (ISUP) recommendations on grade group distribution and concordance with radical prostatectomy (RP). Materials and Methods Overall, 655 biopsy‐naïve patients diagnosed by magnetic resonance imaging (MRI) targeted and systematic biopsies for Prostate Imaging Reporting and Data System score ≥3 lesions were identified from a prospectively maintained database from 2016 and 2022. Clinically significant prostate cancer was detected in 249 patients, of whom 69 underwent RP. Wilcoxon signed rank and McNemar's tests were used to compare the ISUP grade group distribution and concordance with RP after applying the 2014 (i.e., highest grade) and 2019 (i.e., global grade) ISUP recommendations, respectively.
Results
Compared to the 2014 ISUP recommendations, the 2019 ISUP recommendations were associated with a significant decrease in ISUP Grade Group 4 (range of difference from −13% to −5%) and an increase in ISUP Grade Group 2 (range of difference from +6% to +11%) in MRI targeted biopsy only, MRI targeted with perilesional biopsies, and MRI targeted with systematic biopsies (all P < 0.01). In patients who underwent RP, a significant decrease in downgrading was observed with all biopsy strategies (range of difference from −19% to −12%; P ≤ 0.008), along with an increase in concordance with RP specimen (range of difference from +12% to +13%; P ≤ 0.02). The use of the 2019 ISUP recommendation was associated with RP specimen a lower treatment burden.
Conclusions
The use of the 2019 ISUP recommendations mitigates the grade migration induced by MRI targeted biopsy and improves the concordance with the final RP specimen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Jules Bordet Institute-Erasme Hospital, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
- Department of Pathology, Jules Bordet Institute-Erasme Hospital, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
- Department of Radiology, Jules Bordet Institute-Erasme Hospital, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.
ORCID-Profile: Romain Diamand
Zitieren
APA
Jabbour, T., Peltier, A., Rocq, L., Sirtaine, N., Lefebvre, Y., Bourgeno, H., Baudewyns, A., Roumeguère, T., & Diamand, R. (2024). Magnetic resonance imaging targeted biopsy in biopsy‐naïve patients and the risk of overtreatment in prostate cancer: a grading issue. BJU International. https://doi.org/10.1111/bju.16221
Vancouver
Jabbour T, Peltier A, Rocq L, Sirtaine N, Lefebvre Y, Bourgeno H, et al. Magnetic resonance imaging targeted biopsy in biopsy‐naïve patients and the risk of overtreatment in prostate cancer: a grading issue. BJU International. 2024. doi:10.1111/bju.16221
BibTeX
@article{Jabbour2024,
author = {Jabbour, Teddy and Peltier, Alexandre and Rocq, Laureen and Sirtaine, Nicolas and Lefebvre, Yolène and Bourgeno, Henri and Baudewyns, Arthur and Roumeguère, Thierry and Diamand, Romain},
title = {Magnetic resonance imaging targeted biopsy in biopsy‐naïve patients and the risk of overtreatment in prostate cancer: a grading issue},
journal = {BJU International},
year = {2024},
doi = {10.1111/bju.16221}
}
EUVIMED